UK-390,957
Sponsors
Pfizer
Conditions
Ejaculation
Phase 2
Assessment of Efficacy and Safety of UK-390,957 in Men With Premature Ejaculation
CompletedNCT00143117
Start: 2004-08-31End: 2005-06-30Target: 460Updated: 2012-11-07
Assessment Of Efficacy and Safety UK-390,957 In Men With Premature Ejaculation
CompletedNCT00219635
Start: 2005-01-31End: 2005-07-31Target: 138Updated: 2012-11-07
Assessment Of Efficacy and Safety Of UK-390,957 In Men With Premature Ejaculation
CompletedNCT00219583
Start: 2004-08-31End: 2005-06-30Target: 460Updated: 2012-11-07
Assessment Of Safety Of UK-390,957
CompletedNCT00219609
Start: 2005-01-31End: 2006-03-31Target: 1058Updated: 2012-11-07